• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Imunon, Inc.

    IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    IMUNON Announces Strategic Investment in Transomic Technologies
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    Imunon Appoints James E. Dentzer to its Board of Directors
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    Imunon Reports Partial Results from Ongoing Non-human Primate Study
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
    From Imunon, Inc.
    Via GlobeNewswire
    Tickers IMNN
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.